共 28 条
- [23] Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) AMERICAN HEART JOURNAL, 2010, 159 (02) : 222 - 230.e2
- [24] Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) (vol 159, pg 222, 2010) AMERICAN HEART JOURNAL, 2010, 160 (01) : 208 - 208
- [25] Optimal care at the end of life (OPAL): study protocol of a prospective interventional mixed-methods study with pretest-posttest-design in a primary health care setting considering the view of general practitioners, relatives of deceased patients and health care stakeholders BMC HEALTH SERVICES RESEARCH, 2019, 19 (1)
- [26] Optimal care at the end of life (OPAL): study protocol of a prospective interventional mixed-methods study with pretest-posttest-design in a primary health care setting considering the view of general practitioners, relatives of deceased patients and health care stakeholders BMC Health Services Research, 19
- [28] The optimal timing for staged non-culprit vessel intervention following primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction and multivessel disease: insights from the British Columbia Cardiac Registry using decision analytical methods JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B3 - B3